Skip to Content

Infanrix HepB

Active Substance: diphtheria toxoid / tetanus toxoid / pertussis toxoid / pertussis haemagglutin filamentous / pertactin / hepatitis B recombinant surface antigen
Common Name: diphtheria, tetanus, acellular pertussis and hepatitis B recombinant, adsorbed vaccine
ATC Code: J07CA
Marketing Authorisation Holder: GlaxoSmithKline Biologicals S.A.
Active Substance: diphtheria toxoid / tetanus toxoid / pertussis toxoid / pertussis haemagglutin filamentous / pertactin / hepatitis B recombinant surface antigen
Status: Withdrawn
Authorisation Date: 1997-07-30
Therapeutic Area: Hepatitis B Diphtheria Whooping Cough Immunization Tetanus
Pharmacotherapeutic Group: Vaccines

Therapeutic Indication

Infanrix HepB is indicated for active immunisation of all infants from the age of 2 months against
diphtheria, tetanus, pertussis and hepatitis B.

The marketing authorisation for Infanrix HepB has been withdrawn at the request of the marketing authorisation holder.

Source: European Medicines Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide